Lipoxin A4 analogs for the treatment and prevention of intestinal fibrosis

Details for Australian Patent Application No. 2007287770 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Fiorucci, Stefano; Parkinson, John

Agent Davies Collison Cave

Pub. Number AU-A-2007287770

PCT Pub. Number WO2008/022807

Priority 60/839,755 23.08.06 US

Filing date 22 August 2007

Wipo publication date 28 February 2008

International Classifications

A61K 31/202 (2006.01)

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/022807 Priority application(s): WO2008/022807

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007287782-Chromium-free, thermally curable corrosion protection composition

2007287751